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Background
During the last decades, researchers have provided a
plethora of therapeutic uses of kaempferol, including anti-
cancer, anti-inflammatory, neuroprotective, anti-oxidative
and anti-oestrogenic activities, making kaempferol a valu-
able compound [1]. However, being a poor water-soluble
compound, kaempferol often has insufficient solubility
and bioavailability [2].To find a solution for this limitation,
this research project mainly focuses on formulating a
kaempferol nanosuspension (KNS) using High Pressure
Homogenisation (HPH), followed by performing physiolo-
gical characterization. Kaempferol nanosuspensions are
supposed to have a better bioavailability in animal models
or even human subjects in future experiments, thereby
reducing oral drug dosage required by consumers.
Methods
A weighed quantity of pure kaempferol (1%w/v) was dis-
persed in ultrapure water. The mixture had undergone
magnetic stirring at 3000rpm for 30 mins. Then the mix-
ture was sonicated using an ultrasonic probe sonicator. The
amplitude was set at 100% for 1 minute. Finally, the mixture
was homogenised by a high pressure homogeniser at 500
Bar, 1100 Bar and 1700 Bar for 10, 20 and 20 cycles respec-
tively. The particle size, chemical and physical characteris-
tics of kaempferol nanosuspension being produced was
compared with that of pure kampferol. The characterization
techniques include Differential Scanning Calorimetry, X-ray
Diffraction, Transmission Electron Microscopy and Fourier
Transform Infrared Spectroscopy. Data was expressed as
mean ±S.E.M. Significance levels for comparison.
Results
The KNS produced by HPH undergone a significant
reduction in particle size (from 2µm to 400nm), but at the
same time, maintaining its original chemical and physical
characteristics, suggesting that this nanosized kaempferol
has similar therapeutic effects as the pure drug.
Conclusions
Nanosuspensions produced by HPH represent an optimal
solution for many poorly soluble substances and, there-
fore, they are still considered as a formulation of first
choice due to the simplicity of the system.
Authors’ details
1International Medical University, Kuala Lumpur, Malaysia. 2University Putra,
Selangor, Malaysia.
Published: 27 October 2015
References
1. Calderon-Montano JM, Burgos-Moron E, Perez-Guerrero C, Lopez-Lazaro M:
A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 2011,
11(4):298-344.
2. Muller RH, Benita S: Emulsion and nanosuspension for the formulation of
poorly soluble drugs. Medpharm Scientific, Stuttgart 1998, 143-143.
doi:10.1186/1753-6561-9-S7-A22
Cite this article as: Qian et al.: Preparing Kaempferol Nanosuspension
(KNS) using High Pressure Homogenization (HPH) technique. BMC
Proceedings 2015 9(Suppl 7):A22.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit1International Medical University, Kuala Lumpur, Malaysia
Full list of author information is available at the end of the article
Qian et al. BMC Proceedings 2015, 9(Suppl 7):A22
http://www.biomedcentral.com/1753-6561/9/S7/A22
© 2015 Qian et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
